Bristol-Myers Squibb Company Celegne Contingent Value Rights (CELG^) closed at $0.12 on November 13, 2026, down 13.0% from the previous close, on volume of 42,554 shares (30-day average 18,550).
Data as of November 13, 2026.
No headlines found.
No press releases found.
No news found.
Bristol-Myers Squibb Company Celegne Contingent Value Rights trades on the stock market under the symbol CELG^.
As of November 13, 2026, CELG^ stock price declined to $0.12 with 42,554 million shares trading.
CELG^ has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, CELG^ traded as high as $.27 and as low as $.02.
CELG^ has outperformed the market in the last year with a price return of +306.0% while the SPY ETF gained +13.4%. CELG^ has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +32.2% and +28.2%, respectively, while the SPY returned -2.8% and -0.2%, respectively.
CELG^ support price is $.10 and resistance is $.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CELG^ shares will trade within this expected range on the day.
